D. Gary Gilliland

Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9

Andrei V. Krivtsov, David Twomey, Zhaohui Feng et al. · Nature · 2006 · 1.5K citations

Developmental Biology, Cell Division, Medicine +8

Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl

Ellen Weisberg, Paul W. Manley, Werner Breitenstein et al. · Cancer Cell · 2005 · 1.5K citations · Full text

Molecular Pharmacology, Mutant Bcr-abl, Medicine +5

Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation

Todd R. Golub, George F. Barker, Michael Lovett et al. · Cell · 1994 · 1.2K citations

Hematological Malignancy, Chromatin, Pdgf Receptor β +8

Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia

Adolfo A. Ferrando, Donna Neuberg, Jane Staunton et al. · Cancer Cell · 2002 · 1.1K citations · Full text

Hematological Malignancy, Novel Oncogenic Pathways, Mixed-phenotype Acute Leukemia +10

Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia

Woo‐Joo Song, Melanie G. Sullivan, Robert D. Legare et al. · Nature Genetics · 1999 · 1.1K citations

Hematological Malignancy, Thrombosis, Acute Myelogenous Leukaemia +11